As previously reported24, 25, the serum levels of tumor necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β) were elevated in NAFLD patients regardless of fibrosis stages (data not shown), suggesting that these factors are related to the presence of fatty liver disease. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.